CLINICAL_TRIALS
trial_result
· 2014-11-05
Clinical Trial Update: Phase II Neoadjuvant in Inflammatory Breast Cancer [Phase 2]
Summary
Phase II neoadjuvant trial in inflammatory breast cancer was terminated, with results posted on 2014-11-05.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-11-05